Abstract:Background: Cardiac troponin is a complex protein consisting of the three subunits I, T and C located in heart muscle cells. When the heart muscle is damaged, it is released into the blood and can be detected. Cardiac troponin I (cTnI) is considered the most reliable and widely accepted test for detecting and confirming acute myocardial infarction. However, there is no current standardization between the commercial assays for cTnI quantification. Our work aims to create a measurement procedure that is traceable to the International System of Units for accurately measuring cardiac cTnI levels in serum samples from patients. Methods: The workflow begins with immobilizing anti-cTnI antibodies onto magnetic nanoparticles to form complexes. These complexes are used to isolate cTnI from serum. Next, trypsin is used to enzymatically digest the isolated cTnI. Finally, the measurement of multiple cTnI peptides is done simultaneously using isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). Results: The maximum antibody immobilization was achieved by combining 1 mg of nanoparticles with 100 μg of antibody, resulting in an average of 59.2 ± 5.7 μg/mg of immobilized antibody. Subsequently, the anti-cTnI-magnetic nanoparticle complex was utilized to develop and validate a method for quantifying cTnI in human serum using ID-LC-MS/MS and a protein calibration approach. The analytical method was assessed regarding linearity and recovery. The developed method enables the quantification of cTnI from 0.7 to 24 μg/L (R > 0.996). The limit of quantification was 1.8 μg/L and the limit of detection was 0.6 μg/L. Intermediate precision was ≤ 9.6% and repeatability was 2.0-8.7% for all quality control materials. The accuracy of the analyzed quality control materials was between 90 and 110%. Total measurement uncertainties for target value assignment (n = 6) were found to be ≤ 12.5% for all levels. Conclusions: The analytical method demonstrated high analytical performance in accurately quantifying cardiac troponin I levels in human serum. The proposed analytical method has the potential to facilitate the harmonization of cTnI results between clinical laboratories, assign target values to secondary certified reference materials and support reliable measurement of cTnI.

Separation and Purification of Human Cardiac Troponin I (ctn I)

Isolation and Purification of Human Cardiac Troponin Ⅰ Using Affinity Chromatography

Extraction and Purification of Human Cardiac Troponin I by Affinity Chromatography

Purification of Skeletal Muscle Troponin C(sTnC) of Rabbits

Purification and Identification of human Myocardial Troponin T

Preparation of monoclonal antibodies against troponin I and development of one-step sandwich ELISA

Extraction,purification of Rabbit Skeletal Muscle Troponin C

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

Expression of cTnI Specific Antigen Sites and Antibodies Detection

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

Establishment of chemiluminescence enzyme immunoassay for detecting human cardiac troponin I

Immunohistochemical analysis of cardiac troponin inhibitor in an experimental model of acute myocardial infarction experimental model and in human tissues.

Construction , Expression of Ctni(28-110Aa)-linker-tnc Fusion Protein and Its Identification

Development of an ID-LC-MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum

Determination of Cardiac Troponin I for the Auxiliary Diagnosis of Acute Myocardial Infarction by Anodic Stripping Voltammetry at a Carbon Paste Electrode.

Two Desired Epitopes of Ctni Benefit for Preparation of Standardized Monoclonal Antibodies.

In-Vitro Diagnostic Reagent Evaluation of Commercially Available Cardiac Troponin I Assay Kits Using H/D Exchange Mass Spectrometry for Antibody-Epitope Mapping

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform

Low-noise fluorescent detection of cardiac troponin I in human serum based on surface acoustic wave separation

Molecular Sieves Materials Modified Carbon Paste Electrodes for the Determination of Cardiac Troponin I by Anodic Stripping Voltammetry

Determination of Cardiac Troponin I by Anodic Stripping Voltammetry at SBA-15 Modified Carbon Paste Electrode